Publikation:

Neuroprotective properties of memantine in different models of excitotoxicity

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2004

Autor:innen

Volbracht, Christiane
van Beek, Johan

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Neurobiology of Aging. Elsevier. 2004, 25(Suppl 2), pp. S412-S413. ISSN 0197-4580. eISSN 1558-1497. Available under: doi: 10.1016/S0197-4580(04)81352-6

Zusammenfassung

Neuronal dysfunction in Alzheimer's disease (AD) may result, in part, from sustained elevations of glutamate levels and increased sensitivity to glutamate, leading to low-level influx of calcium into neurons, impaired neuronal homeostasis and eventually neurodegeneration. Agents that specifically block the pathological stimulation of glutamate receptors, mainly the N-methyl-D-asparate receptor (NMDA-R) might be anticipated to restore physiological function of neurons and thereby have diseasemodifying effects in AD. Previous attemps to use NMDA-R antagonists to retard the progression of AD have been hindered by the psychotomimetic and cardiovascular effects of these drugs. The tolerability of clinically used uncompetitive NMDA-R antagonist memantine is highly dependent on changes in membrane potential and the drug's fast channel unbloeking kinetics. Memantine blocks sustained NMDA-R activation under pathological conditions and rapidly leaves the NMDA-R channel upon transient physiological activation. Objective: We investigated the neuroprotective properties of memantine in cellular models of different complexity. Methods: Organotypic rat hippocampal slices and murine cerebellar granule cell cultures were exposed to different direct or indirect excitotoxins. Death was measured by counting neurons with condensed nuclei. Results: First, an established model was chosen based on the known pharmacological properties of memantine, in order to find relevant concentrations for cell culture expriments. Memantine protected rat neurons in organotypic hippocampal slices from NMDA-indueed excitotoxicity within micromolar range. Next, we tested memantine within the previously determined dose range in neuronal stress models, which are dependent on excitation of cells by endogenous glutamate. Memantine protected routine cerebellar granule cells from apoptosis induced by the mitochondrial toxin 1-methyl-4-phenylpyridinium (MPP+). Furthermore, neuronal apoptosis induced by the pathophysiologicai mediator nitric oxide (NO) released from S-nitrosoglutathione (GSNO) was inhibited by memantine. Additionally, memantine prevented apoptosis induced by oxygen-glucose deprivation (OGD), a model of cerebral isehemia, in cerebellar granule cells. Conclusion: These findings support a beneficial effect of NMDA-R inhibition by memantine in different apoptotic models.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690VOLBRACHT, Christiane, Johan VAN BEEK, Marcel LEIST, 2004. Neuroprotective properties of memantine in different models of excitotoxicity. In: Neurobiology of Aging. Elsevier. 2004, 25(Suppl 2), pp. S412-S413. ISSN 0197-4580. eISSN 1558-1497. Available under: doi: 10.1016/S0197-4580(04)81352-6
BibTex
@article{Volbracht2004Neuro-52216,
  year={2004},
  doi={10.1016/S0197-4580(04)81352-6},
  title={Neuroprotective properties of memantine in different models of excitotoxicity},
  number={Suppl 2},
  volume={25},
  issn={0197-4580},
  journal={Neurobiology of Aging},
  pages={S412--S413},
  author={Volbracht, Christiane and van Beek, Johan and Leist, Marcel},
  note={Meeting Abstract}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52216">
    <dc:creator>van Beek, Johan</dc:creator>
    <dc:creator>Volbracht, Christiane</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-12-22T09:18:37Z</dcterms:available>
    <dcterms:abstract xml:lang="eng">Neuronal dysfunction in Alzheimer's disease (AD) may result, in part, from sustained elevations of glutamate levels and increased sensitivity to glutamate, leading to low-level influx of calcium into neurons, impaired neuronal homeostasis and eventually neurodegeneration. Agents that specifically block the pathological stimulation of glutamate receptors, mainly the N-methyl-D-asparate receptor (NMDA-R) might be anticipated to restore physiological function of neurons and thereby have diseasemodifying effects in AD. Previous attemps to use NMDA-R antagonists to retard the progression of AD have been hindered by the psychotomimetic and cardiovascular effects of these drugs. The tolerability of clinically used uncompetitive NMDA-R antagonist memantine is highly dependent on changes in membrane potential and the drug's fast channel unbloeking kinetics. Memantine blocks sustained NMDA-R activation under pathological conditions and rapidly leaves the NMDA-R channel upon transient physiological activation. Objective: We investigated the neuroprotective properties of memantine in cellular models of different complexity. Methods: Organotypic rat hippocampal slices and murine cerebellar granule cell cultures were exposed to different direct or indirect excitotoxins. Death was measured by counting neurons with condensed nuclei. Results: First, an established model was chosen based on the known pharmacological properties of memantine, in order to find relevant concentrations for cell culture expriments. Memantine protected rat neurons in organotypic hippocampal slices from NMDA-indueed excitotoxicity within micromolar range. Next, we tested memantine within the previously determined dose range in neuronal stress models, which are dependent on excitation of cells by endogenous glutamate. Memantine protected routine cerebellar granule cells from apoptosis induced by the mitochondrial toxin 1-methyl-4-phenylpyridinium (MPP+). Furthermore, neuronal apoptosis induced by the pathophysiologicai mediator nitric oxide (NO) released from S-nitrosoglutathione (GSNO) was inhibited by memantine. Additionally, memantine prevented apoptosis induced by oxygen-glucose deprivation (OGD), a model of cerebral isehemia, in cerebellar granule cells. Conclusion: These findings support a beneficial effect of NMDA-R inhibition by memantine in different apoptotic models.</dcterms:abstract>
    <dcterms:title>Neuroprotective properties of memantine in different models of excitotoxicity</dcterms:title>
    <dcterms:issued>2004</dcterms:issued>
    <dc:language>eng</dc:language>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-12-22T09:18:37Z</dc:date>
    <dc:rights>terms-of-use</dc:rights>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>van Beek, Johan</dc:contributor>
    <dc:contributor>Volbracht, Christiane</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/52216"/>
    <dc:creator>Leist, Marcel</dc:creator>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Meeting Abstract
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Nein
Diese Publikation teilen